Immunotherapy With Radiotherapy and Stage IV NSCLC Prognosis Immunotherapy With Radiotherapy and Stage IV NSCLC Prognosis
These findings suggest that stage IV NSCLC patients who receive radiotherapy in addition to immunotherapy may not realize significant improvements in prognosis.Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer